ESSENCE-Q- used as a screening tool for neurodevelopmental problems in public health checkups for young children in south Japan by Hatakenaka, Yuhei et al.
© 2017 Hatakenaka et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php 
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you 
hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission 
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Neuropsychiatric Disease and Treatment 2017:13 1271–1280
Neuropsychiatric Disease and Treatment Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
1271
O r i g i N a l  r e s e a r c h
open access to scientific and medical research
Open access Full Text article
http://dx.doi.org/10.2147/NDT.S132546
esseNce-Q – used as a screening tool for 
neurodevelopmental problems in public health 
checkups for young children in south Japan
Yuhei hatakenaka1,2
hitoshi Ninomiya3
eva Billstedt2
elisabeth Fernell2
christopher gillberg2
1Kochi gillberg Neuropsychiatry 
centre, Kochi Prefectural Medical and 
Welfare center, Kochi, Japan; 2gillberg 
Neuropsychiatry centre, sahlgrenska 
academy, University of gothenburg, 
gothenburg, sweden; 3integrated 
centre for advanced Medical 
Technologies, Kochi University 
Medical school, Kochi, Japan
Background: Screening for developmental disorders is an important task for Child Health 
Care. The concept of ESSENCE (early symptomatic syndromes eliciting neurodevelopmental 
clinical examinations) was created to cover all types of early developmental disorders and the 
ESSENCE-Questionnaire (ESSENCE-Q containing 12 questions with possible total scores 
ranging from 0 to 22) was developed as a tool for early detection of these disorders. The aim 
of this study was to perform a validation study in a public health situation in Japan.
Methods: The psychometric properties of the ESSENCE-Q, completed by mothers, public 
health nurses (PHNs), and psychologists at 18-month (n=143 children) and 36-month (n=149 
children) checkups were evaluated in a small city of Japan. Results were validated against clinical 
ESSENCE diagnoses. Receiver operating characteristic curves were generated and compared 
by using the area under the curve (AUC). Optimal cutoff values were explored.
Results: At the 18-month checkup, AUC by mothers was 0.72, by PHNs 0.86, and by psy-
chologists 0.82. An optimal cutoff was 3 with a high negative predictive value (NPV). At the 
36-month checkup, AUC by mothers was 0.57, by PHNs 0.82, and by psychologists 0.87. 
Optimal cutoff was 2 with high NPV.
Conclusion: The ESSENCE-Q completed by PHNs and psychologists had good diagnostic 
validity. The results suggested that almost all children scoring under cutoff would not have any 
ESSENCE problems/diagnoses.
Keywords: ESSENCE, questionnaire, public health nurse, receiver operating characteristic, 
ROC, area under the curve, AUC, optimal cutoff, negative predictive value, NPV
Introduction
Screening for chronic diseases has been defined as:
[...] the presumptive identification of unrecognized disease or defect by application of 
tests, examinations or other procedures, which can be applied rapidly […]. Persons 
with positive or suspicious finding must be referred to their physician for diagnosis 
and necessary treatment.1
If “disease or defect” is changed to “neurodevelopmental disorder or problem” and 
“to their physician” to “for neurodevelopmental assessment,” then this definition 
can also be applied to developmental screening. The main aim of developmental 
screening was to assess a child’s risk of developmental disorders.2,3 Early identi-
fication of neurodevelopmental problems is one of the most important tasks for 
public health.4 Many outcome studies of children with developmental disorders 
have demonstrated that early tailored interventions are important to maximize the 
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individual child’s potential.3 There is growing evidence 
that, even when a precise diagnosis cannot be established, 
early intervention taking the child’s basic impairment into 
account is important.5–8
ESSENCE (early symptomatic syndromes eliciting neu-
rodevelopmental clinical examinations) is a concept that was 
introduced with a view to alert clinicians and researchers to 
the complexity and overlap of different neurodevelopmental 
disorders/problems including autism spectrum disorder 
(ASD), attention-deficit/hyperactivity disorder (ADHD), 
oppositional defiant disorder (ODD), tic disorders (TDs), 
developmental coordination disorder (DCD), speech and 
language disorder (SLD), intellectual developmental dis-
order (IDD), borderline intellectual functioning (BIF), and 
other non-specific learning difficulties (LDs).9 If a child 
before 5 years of age has at least one (usually several) 
problem lasting more than several months in the following 
12 areas – general development, communication/language, 
social interrelatedness, perception, motor coordination, 
attention/“listening,” activity, “behavior,” mood, feeding, 
sleep, and/or episodes/absences – this should be seen as a 
red flag for possible neurodevelopmental disorders. Unrec-
ognized and “untreated” ESSENCE may predispose to adult 
psychiatric and/or physical disorders. With regard to preva-
lence, at least 10% of children aged ,18 years are affected 
by ESSENCE.9 Identifying problems under the ESSENCE 
concept in young children and monitoring child development 
would possibly reduce the risk of later maladjustment.
The ESSENCE-Questionnaire (ESSENCE-Q) is a 
screening tool designed to help clinicians and researchers to 
identify children with ESSENCE (or neurodevelopmental) 
problems.10 The ESSENCE-Q is intended for use in both 
clinical practice and population research. It is proposed 
to be useful as a questionnaire to be completed by parents 
and/or caregivers or as a brief interview by a specialist. 
It has already been shown that the ESSENCE-Q can be useful 
as a parent questionnaire in a neurodevelopmental clinic.11 
It could also be useful in a public health setting as a parent 
questionnaire or as an interview questionnaire and/or as the 
basis for an observation record.
Screening at child health care centers has proven to be 
a valuable method to identify developmental disorders in 
young children. Previous studies12 have demonstrated the 
use of a language screening, performed by the health nurse, 
and that such screening identifies also children with other 
ESSENCE problems. Such screening methods include the 
professional assessment supplemented by reports from par-
ents. The value of the ESSENCE-Q lies in its short format 
and its broad approach, covering different developmental 
areas. It can be used to obtain both parents’ and professionals’ 
concerns at the child’s health checkups and will thereby 
increase the validity of the screening.
In Japan, according to the Maternal and Child Health 
Law,13 all children are invited to take part in health checkups, 
first during 18–24 months (“18-month checkups”) and second 
during 36–48 months (“36-month checkups”). Municipali-
ties have responsibility for these checkups, and the rate of 
attendance is ~95%.14 Therefore, these checkups provide 
good opportunities to identify the children with neurode-
velopmental disorders.15 The ESSENCE-Q in 18-month and 
36-month checkups in a small city of Japan was used as a 
parent questionnaire to mothers and as a parent-interview and 
child-observation tool used by public health nurses (PHNs) 
and psychologists who were specialized in neurodevelop-
mental disorders (specialized psychologists).
The aims of the present study were to 1) evaluate the 
validity of the ESSENENCE-Q completed by mothers, 
PHNs, and specialized psychologists in a public health setting 
and 2) explore an optimal cutoff score of the ESSENCE-Q 
at 18- and 36-month checkups.
Methods
This is a prospective, population-based, observational cohort 
study. Data on two separate groups of children who came 
to health care centers in Kami City, Kochi, Japan, from 
April 2014 to March 2015 were collected. In Kami City, 
parents of children who were 18 or 42 months of age during 
the period were invited to 18- or 36-month checkups. PHNs 
in the city have been working with specialized psycholo-
gists, and they have had on-the-job training in screening of 
neurodevelopmental disorders for several years. They also 
participated in seminars about ESSENCE and related prob-
lems, including about the ESSENCE-Q.
esseNce-Q
Procedures
The ESSENCE-Q is a brief one-page “quick and easy” 
questionnaire containing 12 items covering concerns relat-
ing to the above-mentioned 12 areas. Response options of 
“Yes,” “Maybe/A little,” or “No” should be checked for each 
item. It is not a diagnostic instrument or an instrument that 
can be used as a proxy for diagnoses, but a screening tool to 
be used in order not to overlook children who need further 
assessments by a developmental specialist.10
All ESSENCE-Q data from mothers who came with their 
child to the 18-month or the 36-month checkup were collected. 
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PHNs and specialized psychologists were engaged in these 
checkups. The mothers, PHNs, and the specialized psycholo-
gists scored the child’s ESSENCE-Q blind to each other.
The ESSENCE-Q was sent to mothers before the 
checkup, and they were asked through letter to complete the 
questionnaire. These ESSENCE-Qs (ESSENCE-Q-M) were 
gathered by receptionists at the checkups. Then, at the check-
ups, the PHNs completed the ESSENCE-Q (ESSENCE-
Q-N) through interview with the mothers and through direct 
observation of the child without any knowledge about the 
ESSENCE-Q-M. Third, specialized psychologists completed 
the ESSENCE-Q (ESSENCE-Q-P) through interview with 
the mothers and through direct observation of the child 
without any knowledge about the ESSENCE-Q-M and the 
ESSENCE-Q-N.
The PHNs and the specialized psychologists used the 
ESSENCE-Q statements as a template for their interviews, 
and sometimes added simple questions (eg, “When did your 
child start walking?”). After the interview and the observa-
tion, they noted their concerns in the ESSENCE-Q.
esseNce diagnoses
At the end of the checkups, a pediatrician with training in the 
field of ESSENCE examined the child and interviewed the 
mother. The child’s entire records with regard to development 
from birth were checked as were the three ESSENCE-Qs. 
Taking all this information into consideration, the pediatri-
cian made a decision as to whether or not the child needed 
to go for further neurodevelopmental examinations. Children 
targeted for further examinations were then examined – on 
another day at the same health center – by a specialized child 
neuropsychiatrist (including interview with the mother). 
If there was any remaining concern regarding neurodevelop-
mental disorders, the child was referred to a neurodevelop-
mental clinic for further investigation by the psychiatrist and 
a team including occupational therapists and psychologists. 
The time periods between the secondary checkup and the first 
assessment at the neurodevelopmental clinic were ,4 months 
(in most cases, 2 months). The child neuropsychiatrist was 
not blind to the results of the ESSENCE-Qs, but these results 
did not form part of his referral decision.
At the neurodevelopmental clinic, assessments covered 
all developmental areas included under the ESSENCE 
umbrella. Overall development, motor and perceptual per-
formance, social communication and related behaviors, social 
interest, joint attention, imitation, play, reciprocal affec-
tive behavior, and insistence on sameness/stereotypies16–18 
were assessed for all children at the first two to three visits. 
For cognitive assessment, the Kyoto Scale of Psychological 
Development 2001 (KSPD2001)19 was used. KSPD is an 
individualized face-to-face test to assess a child’s develop-
ment in the areas of fine and gross motor functions, non-verbal 
reasoning, visuospatial perceptions, interpersonal relation-
ships, socializations, and verbal abilities.19 KSPD2001 has 
excellent psychometric properties, and the results are closely 
correlated with the Bayley Scales of Infant Development.20 For 
the assessment of social and communication development, the 
Diagnostic Interview for Social and Communication Disorders 
(DISCO)21 was used. The DISCO is widely used as an assess-
ment tool for autism spectrum conditions. The interview is 
semistructured and covers a wide range of behaviors associ-
ated with the ASD phenotype. It is suitable for use with all 
ages and levels of ability. It enables to identify specific features 
found in ASD. The Strengths and Difficulties Questionnaire 
(SDQ)22 for parents of 2- to 4-year olds was used. SDQ covers 
child mental health and developmental aspects, including child 
behavior, emotions, and relationships. It also addresses impact 
and duration of symptoms, distress in the child, impairment 
in different settings, and burden to others. SDQ can be used 
as a screening tool for several types of neurodevelopmental 
disorders, such as ASD and ADHD. Unstructured clinical 
observations at the clinic and reports/interviews from parents 
and preschool teachers were collected throughout the exami-
nation period. Motor-perceptual performance was examined 
at clinical observations. The diagnostic evaluations were 
done at least at five different sessions separated by a mini-
mum of 2 weeks.23 For the children who were referred from 
the 18-month checkups, definite diagnoses were given at or 
after 30 months. The International Statistical Classification 
of Diseases-10/Diagnostic and Statistical Manual of Mental 
Disorders-IV criteria for diagnoses of child psychiatric/
neurodevelopmental disorders were used throughout.
statistical analysis
ESSENCE-Q items were rated as 0 for “No,” 1 for “Maybe/a 
little,” and 2 for “Yes.” The range of possible scores was 
0–24. If four or more (.10%) of the 36 items, collapsed from 
the three ESSENCE-Qs, were unchecked by mother, PHS, 
or specialized psychologist, then this case was excluded. 
Unchecked items were otherwise rated as 0. These overall 
ESSENCE-Q scores were used as continuous variables and 
generated receiver operating characteristic (ROC) curves 
and compared the area under the curve (AUC) to evalu-
ate the validity of ESSENCE-Q-M, ESSENCE-Q-N, and 
ESSENCE-Q-P separately. In addition, the optimal cutoff 
values for screening in health checkups from the ROC 
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curves were explored. For a developmental screening, the 
best sensitivity and specificity balance is around 0.70–0.80 
for both.5,24 Sensitivity should be higher than specificity so 
as not to miss children with problems.25 When an optimal 
cutoff value fulfilling these conditions was found, the sen-
sitivity, specificity, positive predictive value (PPV), and 
negative predictive value (NPV) were calculated. The data 
from 18- and 36-month checkups were analyzed separately. 
All statistical analyses were done by R version 3.1.3 (The 
R Foundation for Statistical Computing, Vienna, Austria). 
Sensitivity, specificity, PPV, and NPV were expressed with 
a 95% confidence interval (CI).
ethics
The institutional ethical boards of Kochi Prefectural Medical 
and Welfare Centre approved the study with parents’ written 
informed consent, No 25-2056.
Results
characteristics of study population
18-month checkups (Figure 1)
During the study period, all 152 children (79 boys and 73 girls) 
were invited to the 18-month checkup and 143 children 
(75 boys and 68 girls, mean age 18.7, standard deviation 
[SD] 0.9) participated. The attendance rate was 94%. Of the 
143 children, 50 (27 boys and 23 girls) (35%) were invited 
to come to the secondary checkup due to developmental 
concerns. However, eight (three boys and five girls) did not 
come to the secondary checkup. Of the remaining 42 children, 
21 (10 boys and 11 girls) were regarded to have normal 
development and 21 (14 boys and 7 girls) were referred to 
the neurodevelopmental clinic. One boy’s family moved out 
from the city and, as a result, 20 (13 boys and 7 girls) came 
to the clinic.
Figure 1 Flowchart of the children in 18-month checkups.
Abbreviation: esseNce, early symptomatic syndromes eliciting neurodevelopmental clinical examinations; esseNce-Q, esseNce-Questionnaire.
143 (75 boys) receive ESSENCE-Q
42 (24 boys)
8 (3 boys) dropped out
9 (4 boys) dropped out
1 (1 boy) dropped out
21 (14 boys)
20 (13 boys)
50 (27 boys)
some ESSENCE-suspicion
15 (10 boys)
with ESSENCE diagnosis
5 (3 boys)
no ESSENCE-suspicion
21 (10 boys)
no ESSENCE-suspicion
93 (48 boys)
no ESSENCE-suspicion
152 (79 boys) available
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Neurodevelopmental diagnoses in the children of the 
18-month checkups
Of the 20 children who came to the clinic, five (three boys 
and two girls) were considered to have a normal develop-
mental trajectory and 15 children (10 boys and 5 girls) were 
given neurodevelopmental diagnoses (10% of all partici-
pants). One third had intellectual problems (IDD, BIF) and 
one third had ADHD. Two had ASD. Table 1 shows diag-
nostic and other information of the 20 children who came to 
the clinic.
Three of the 143 children (three boys without a diag-
nosis) were excluded because of missing data. The eight 
children who did not come for the second assessment and 
the child who moved from the area were excluded (because 
it could not be ascertained whether or not they actually had 
an ESSENCE diagnosis), leaving 131 (63 boys and 68 girls, 
mean age 18.7, SD 0.8, 92% of all the participants) for 
statistical analyses.
“Thirty six-month checkups” performed at a mean 
age of 42 months (Figure 2)
During the period, 158 children (77 boys and 81 girls) 
were invited to the “36-month checkups” (which in 
reality occurred at 42 months in the majority of cases) and 
149 children (73 boys and 76 girls, mean age 42.0 months, 
SD 1.0) participated. The attendance rate was 94%. Of the 
149 children, 38 (19 boys and 19 girls) (26%) were invited 
to come to the secondary checkup due to developmental con-
cerns. However, five (five boys) did not come to the second-
ary checkup. In the remaining 33 children, 17 were regarded 
to have a normal development (6 boys and 11 girls) and 16 
(8 boys and 8 girls) were referred to the neurodevelopmental 
clinic. A family of a boy and another family of a girl moved 
out from the area and, as a result, 14 (7 boys and 7 girls) came 
to the clinic.
Neurodevelopmental diagnoses in the children 
of the 42-month checkups
All children who came to the clinic were given neurodevelop-
mental diagnoses (9% of all participants). Twelve had ADHD 
and two had ASD. Ten had two or more diagnoses. Table 2 
shows diagnostic and other information of the 14 children 
who were referred to the clinic.
Three of the 149 children (three boys, one of whom had 
a diagnosis) were excluded because of missing data. Five 
children who did not come to the secondary assessment and 
two children who did not come for full clinical assessment 
were also excluded, leaving 139 (64 boys and 75 girls, 
mean age 42.0, SD 1.0, 93% of all the participants) for 
statistical analyses.
Table 1 Diagnosis and background information of the 21 children referred to the clinic from 18-month checkups
Number Gender Age at the first 
checkup (months)
Age at the first 
visit (months)
ESSENCE diagnoses/conditions 
at age (months)
1 Boy 19 21 Normal developmental trajectory (44)
2 Boy 18 21 Normal developmental trajectory (33)
3 Boy 18 19 asD (33)
4 Boy 18 26 aDhD (41), iDD (41)
5 Boy 18 20 aDhD (39), DcD (39)
6 Boy 19 38 BiF (39)
7 Boy 19 20 asD (36)
8 Boy 18 21 Normal developmental trajectory (30)
9 Boy 21 22 iDD (30)
10 Boy 19 22 iDD (33)
11 Boy 19 25 aDhD (32)
12 Boy 18 29 slD (30)
13 Boy 18 20 iDD (30)
14* Boy 18 N/a N/a
15 girl 18 21 aDhD (42), slD (43)
16 girl 19 23 Normal developmental trajectory (38)
17 girl 18 22 slD (37)
18 girl 19 28 Normal developmental trajectory (30)
19 girl 18 20 slD (42)
20 girl 18 21 aDhD (36)
21 girl 18 19 iDD (30)
Note: *lost to follow-up due to changing address.
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; ASD, autism spectrum disorder; BIF, borderline intellectual functioning; DCD, developmental coordination 
disorder; esseNce, early symptomatic syndromes eliciting neurodevelopmental clinical examinations; iDD, intellectual developmental disorder; slD, speech and language 
disorder; N/a, not applicable.
 
N
eu
ro
ps
yc
hi
at
ric
 D
ise
as
e 
an
d 
Tr
ea
tm
en
t d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
0.
20
9.
11
6.
21
 o
n 
21
-J
an
-2
02
0
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Neuropsychiatric Disease and Treatment 2017:13submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1276
hatakenaka et al
esseNce-Q scores
18-month checkups (Figure 3, Table 3)
Overall ESSENCE-Q-M, ESSENCE-Q-N, and ESSENCE-Q-P 
scores produced AUC values (95% CI) of 0.69 (0.52–0.86), 0.92 
(0.86–0.97), and 0.85 (0.74–0.96), respectively. For ESSENCE-
Q-M, an optimal cutoff value that fulfilled the conditions 
mentioned above was not found. For ESSENCE-Q-N, the 
optimal cutoff value was set at 3, which showed a sensitivity 
of 0.93 (95% CI: 0.66–1.00) a specificity of 0.74 (95% CI: 
0.66–0.82), a PPV 0.30 (95% CI: 0.17–0.46), and an NPV 0.99 
(0.94–1.00). For ESSENCE-Q-P, an optimal cutoff value was 
set as 3, which showed a sensitivity of 0.86 (95% CI: 0.57–0.98), 
a specificity of 0.75 (95% CI: 0.66–0.83), a PPV of 0.29 
(95% CI: 0.16–0.46), and an NPV of 0.98 (95% CI: 0.92–1.00).
36-month checkups (Figure 4, Table 4)
Overall ESSENCE-Q-M, ESSENCE-Q-N, and ESSENCE-
Q-P scores produced AUC values (95% CI) of 0.63 
(0.46–0.81), 0.84 (0.73–0.95), and 0.82 (0.69–0.94). For 
ESSENCE-Q-M, an optimal cutoff value that fulfilled the 
conditions mentioned above was not found. For ESSENCE-
Q-N, the optimal cutoff value was set as 2, which showed 
a sensitivity of 0.86 (95% CI: 0.57–0.98), a specificity 0.70 
(95% CI: 0.61–0.76), a PPV of 0.24 (95% CI: 0.13–0.38), 
and an NPV of 0.98 (95% CI: 0.92–1.00). For ESSENCE-
Q-P, the optimal cutoff value was set as 2, which showed a 
sensitivity of 0.86 (95% CI: 0.57–0.98), a specificity of 0.66 
(95% CI: 0.57–0.75), a PPV of 0.22 (95% CI: 0.12–0.36), 
and an NPV of 0.98 (95% CI: 0.92–1.00).
Differences between boys and girls
Results were subdivided according to gender. There was 
a clear trend toward boys having “better” validity data 
than the girls. In the 18-month checkups, sensitivity was 
0.89 and 0.89 for boys compared to 1.00 and 0.80 for 
girls at ESSENCE-Q-N and ESSENCE-Q-P, respectively. 
Figure 2 Flowchart of the children in 36-month checkups.
Abbreviation: esseNce, early symptomatic syndromes eliciting neurodevelopmental clinical examinations; esseNce-Q, esseNce-Questionnaire.
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Figure 3 rOc curves for predicting esseNce diagnoses at 18-month checkups 
based on overall esseNce-Q score in esseNce-Q-M (Mtotal), esseNce-Q-N 
(Ntotal), and esseNce-Q-P (Ptotal).
Abbreviations: esseNce, early symptomatic syndromes eliciting neuro-
developmental clinical examinations; esseNce-Q, esseNce-Questionnaire; rOc, 
receiver operating characteristic.
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Table 2 Diagnosis and background information of the 16 children referred to the clinic from 36-month checkups
No Gender Age at the first 
checkup (months)
Age at the first 
visit (months)
ESSENCE diagnoses/ 
conditions at age (months)
1 Boy 41 46 asD (48), DcD (48), Tics (48)
2 Boy 42 47 BiF (49), aDhD (56)
3 Boy 42 43 asD (45), aDhD (58)
4 Boy 42 43 DcD (44), aDhD (51)
5 Boy 41 45 aDhD (51), slD (51)
6 Boy 41 44 aDhD (57), slD (57)
7* Boy 43 N/a N/a
8** Boy 42 44 aDhD (52), BiF (52)
9 girl 43 51 aDhD (59)
10 girl 43 45 DcD (45), Tics (45), saD (45), 
congenital tremor (45)
11 girl 41 46 aDhD (56)
12 girl 43 44 aDhD (59), BiF (59)
13 girl 42 45 aDhD (59)
14 girl 42 45 aDhD (59)
15* girl 43 N/a N/a
16 girl 41 47 aDhD (53), raD (53)
Notes: *lost to follow-up due to changing address. **excluded from rOc analysis because of missing data.
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; ASD, autism spectrum disorder; BIF, borderline intellectual functioning; DCD, developmental coordination 
disorder; esseNce, early symptomatic syndromes eliciting neurodevelopmental clinical examinations; N/a, not applicable; raD, reactive attachment disorder; saD, social 
anxiety disorder; slD, speech and language disorder; rOc, receiver operating characteristic.
Specificity was 0.75 and 0.71 for boys compared to 0.74 
and 0.79 for girls. PPV was 0.35 and 0.32 for boys com-
pared to 0.25 and 0.25 for girls. NPV was 0.98 and 0.98 for 
boys compared to 1.00 and 0.98 for girls. In the 36-month 
checkups, sensitivity was 1.00 and 0.86 for boys compared 
to 0.71 and 0.86 for girls at ESSENCE-Q-N and ESSENCE-
Q-P, respectively. Specificity was 0.75 and 0.70 for boys 
compared to 0.65 and 0.63 for girls. PPV was 0.33 and 0.26 
for boys compared to 0.17 and 0.19 for girls. NPV was 1.00 
and 0.98 for boys compared to 0.96 and 0.98 for girls. The 
significance of the differences was not tested because of 
small numbers.
attrition results
Of the nine children in the 18-month checkups and the 
seven children in the 36-month checkups who could not 
be diagnostically assessed (and who were suspected to be 
cases), five and six respectively were screened positive. This 
rate (69% of all who dropped out after initial screening) is 
higher than the rate (36%) for those who were retained for 
the statistical analyses.
Table 3 AUC, sensitivity, specificity, PPV, and NPV of the three 
esseNce-Qs in 18-month checkups
18 months 
(n=131)
ESSENCE-Q-M ESSENCE-Q-N ESSENCE-Q-P
aUc 0.69 (0.52–0.86) 0.92 (0.86–0.97) 0.85 (0.74–0.96)
Optimal 
cutoff score
N/a Ntotal $3 Ptotal $3
sensitivity N/a 0.93 (0.66–1.00) 0.86 (0.57–0.98)
Specificity N/a 0.74 (0.66–0.82) 0.75 (0.66–0.83)
PPV N/a 0.30 (0.17–0.46) 0.29 (0.16–0.46)
NPV N/a 0.99 (0.94–1.00) 0.98 (0.92–1.00)
Note: Figures in parentheses indicate 95% ci.
Abbreviations: AUC, area under the curve;  CI, confidence interval; ESSENCE-Q, 
esseNce-Questionnaire; esseNce-Q-M, esseNce-Q completed by mother; 
esseNce-Q-N, esseNce-Q completed by public health nurse; esseNce-Q-P, 
ESSENCE-Q completed by specialized psychologist; NPV, negative predictive value; 
N/A, not applicable; PPV, positive predictive value.
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Discussion
According to the results obtained from these 18- and 
36/42-month checkups – with AUCs for ESSENCE-Q-N 
and ESSENCE-Q-P of 0.8–0.9 and NPVs of almost 1.0 – the 
ESSENCE-Q used by PHNs and specialized psychologists 
seems to hold promise as a general population screening 
tool for neurodevelopmental disorders in young children. 
However, the validity of ESSENCE-Q-M (showing an AUC 
of 0.69 in the 18-month and 0.63 in the 36-month checkup) 
seems not sufficient for a screening tool when used alone. 
Given that individuals who dropped out were much more 
often screen positive than were those who remained in 
the study (and hence much more likely to be real cases), 
the estimates of psychometric validity presented here are 
probably conservative. An underlying reason for the better 
validity of the ESSENCE-Q rating by PHNs and specialized 
psychologists, compared to the mothers, might be that the 
professionals’ experiences contributed to a more realistic 
assessment of the children’s development. The ESSENCE-Q 
in its present format appears to possibly have a better validity 
for screening boys – at least at the 36/42-monthcheckup – as 
compared with girls with neurodevelopmental disorders in 
the general population, but numbers after subdivision accord-
ing to gender were too small to make other than very tenta-
tive suggestions. However, the possibility that symptoms of 
a developmental disorder in some girls may not be obvious 
enough at the time of screening was not excluded.
Nurses working in maternal and child health are the key 
professionals for early identification of neurodevelopmental 
disorders in many western countries,26 and, in Japan, PHNs 
are expected to take this role.27 If a trained PHN’s identifica-
tion of children with ESSENCE at the first stage of screening 
can be shown to be valid when compared with the result of 
the ESSENCE-Q assessment by a specialized psychologist, 
the PHN might then even be suggested to take the role of 
“specialist” when it comes to referral for full neurodevel-
opmental assessment. Given that the PHNs who joined this 
study had enough knowledge and experiences with regard 
to neurodevelopmental disorders in young children, further 
studies are needed to determine whether or not the results 
of this study can be generalized to other, larger general 
population samples.
In the 18-month checkup, a cutoff value of 3 satisfied 
our requirement (ie, that both sensitivity and specificity 
be at least 0.7–0.8, and sensitivity . specificity) for 
ESSENCE-Q-N and ESSENCE-Q-P. The high NPVs (0.98 
in ESSENCE-Q-N and in ESSENCE-Q-P) suggested that 
almost all children with score ,3 in the ESSENCE-Q by 
a PHN (or by a psychologist) would be free of ESSENCE 
problems/diagnoses. On the other hand, the low PPVs (0.30 
in ESSENCE-Q-N and 0.29 in ESSENCE-Q-P) suggested 
that the result on the ESSENCE-Q should not be taken to 
mean that all children over the cutoff value would have 
neurodevelopmental diagnoses. Nevertheless, screen-
positive children in this cohort will be followed-up, and 
if later concerns regarding neurodevelopmental problems 
arise, they will be referred for new neurodevelopment 
Table 4 AUC, sensitivity, specificity, PPV, and NPV of the three 
esseNce-Qs in 36-month checkups
36 months 
(n=139)
ESSENCE-Q-M ESSENCE-Q-N ESSENCE-Q-P
aUc 0.63 (0.46–0.81) 0.84 (0.73–0.95) 0.82 (0.69–0.94)
Optimal 
cutoff score
N/a Ntotal $2 Ptotal $2
sensitivity N/a 0.86 (0.57–0.98) 0.86 (0.57–0.98)
Specificity N/a 0.70 (0.61–0.76) 0.66 (0.57–0.75)
PPV N/a 0.24 (0.13–0.38) 0.22 (0.12–0.36)
NPV N/a 0.98 (0.92–1.00) 0.98 (0.92–1.00)
Note: Figures in parentheses indicate 95% ci.
Abbreviations: AUC, area under the curve;  CI, confidence interval; ESSENCE-Q, 
esseNce-Questionnaire; esseNce-Q-M, esseNce-Q completed by mother; 
esseNce-Q-N, esseNce-Q completed by public health nurse; esseNce-Q-P, 
ESSENCE-Q completed by specialized psychologist; NPV, negative predictive value; 
N/A, not applicable; PPV, positive predictive value.
Figure 4 rOc curves for predicting esseNce diagnoses at 36-month checkups 
based on overall esseNce-Q score in esseNce-Q-M (Mtotal), esseNce-Q-N 
(Ntotal), and esseNce-Q-P (Ptotal).
Abbreviations: esseNce, early symptomatic syndromes eliciting neuro-
developmental clinical examinations; esseNce-Q, esseNce-Questionnaire; 
esseNce-Q-M, esseNce-Q completed by mother; esseNce-Q-N, esseNce-Q 
completed by public health nurse; esseNce-Q-P, esseNce-Q completed by 
specialized psychologist; rOc, receiver operating characteristic.
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screening tool for neurodevelopmental problems
assessment. In the 36/42-month checkup, with a cutoff 
of 3, the sensitivity was 0.71–0.64 and the specificity was 
0.81–0.79 for ESSENCE-Q-N and ESSENCE-Q-P. This was 
slightly under our required level. When the cutoff was set 
at 2, the sensitivity and the specificity almost satisfied our 
requirement for ESSENCE-Q-N and ESSENCE-Q-P. NPVs 
were almost 1.0 and PPVs (0.24 in ESSENCE-Q-N and 
0.22 in ESSENCE-Q-P) were similar to levels at 18-month 
checkups. These cutoff values (3 in 18-month checkups 
and 2 in 36-month checkups) are almost identical to those 
suggested by the originator of the ESSENCE-Q (“Yes” $1 
or “Maybe/a little” $3).
The results of the ESSENCE-Q by mothers, PHNs, and 
specialized psychologists were known to the pediatrician who 
made the decision to refer or not for secondary checkup. This 
is a clear limitation of the present study. However, given that 
the study was performed in a routine clinical environment 
that already included some kind of explicit screening for 
neurodevelopmental disorders, it would have been ethically 
problematic to recruit a representative population if parent-
reported or observed problems would not have influenced 
the decision to refer for in-depth assessment. The strength 
of the study includes its population-based nature, the very 
thorough clinical examination of the children, and the fact 
that the screening procedure used is clinically applicable 
as it stands (“quick and easy” and based on a one-page 
questionnaire).
There are several studies that have claimed that the 
developmental concerns expressed by parents should be taken 
seriously by specialists.28,29 It was previously shown that the 
ESSENCE-Q completed by parents of children referred for 
neurodevelopmental assessment can be a useful screening 
tool for neurodevelopmental disorders in a clinical setting.11 
However, given that the numbers were small in both the pres-
ent and the clinical study, further research is needed before 
generalizable conclusions can be drawn.
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